Studies and Science

Effect of Opioid vs Nonopioid Medications on Pain-Related Function in Patients With Chronic Back Pain or Hip or Knee Osteoarthritis Pain

By Dr. Erin E Krebs, MD, MPH and Amy Gravely, MA; Sean Nugent. BA; Agnes C Jensen, MPH; Beth DeRonne, PharmO; Elizabeth S. Goldsmith, MD, MS; Kurt Kroenke, MO; Matthew J. Bair; Siamak Noorbaloochi. PhD *American Medical Association*

Role of Low-Level Laser Therapy in Neurorehabilitation (Transcranial)

av Javad T. Hashmi, Ying-Ying Huang, Bushra Z. Osmani, Sulbha K. Sharma, Margaret A. Naeser & Michael R. Hamblin

NPF - Effects of Low-Level Laser Therapy in Autism Spectrum Disorder

av Gerry Leisman, Calixto Machado, Yanin Machado & Mauricio Chinchilla-Acosta

The Use of Low Level Laser Therapy (LLLT )For Musculoskeletal Pain

av Howard B Cotler, Roberta T Chow, Michael R Hamblin & James Carroll.


av Erchonia Medical Inc.

The need for other pain treatment forms

av Amanda MacMillan

Denise H. Hawkins, M. Tech and Heidi Abrahamse, PhD - Faculty of Health, University of Johannesburg,

av Denise H. Hawkins & Heidi Abrahamse

Artiklar och föreläsningar av doktorer

Dr. Silverman - Back Pain Dynamic Chiro Aug2018


Dr. Silverman - Violet Laser (Florida Chiropractic Association)

The gut-brain axis in health and disease

Dr. Jerome Rerucha, DC, BS, CSCS, CHPS

An Integrative Approach for Plantar Fasciitis

DR. Kerry Zang, DPM - Foot and Ankle Pathology

Inflammatory & Degenerative Processes in Tendons, Capsules & Fascia, Tendonitis and Peripheral Neuropathy.

Pain Management: Orthopedics & Sports medicine by Dr. Robert Sullivan

A modern evidence based, none pharmaceutical approach using 635nm low level laser device

A double blind randomised controlled study on Perhiperal Neuropathy in Diabetes

A double blind randomised controlled study to investigate the effects of Low Level Laser Therapy on Perhiperal Neuropathy in Diabetes Dr. Robert Sullivan.

Dr. Huang - Biphasic Dose Response in LLLT (Harvard)

Refers to over 100 level III randomized clinical studies.

Dr. Richard Silverstein, DPM "Low Level Laser Technology and Your Practice"

It’s a great time to incorporate this technology into clinical practice - "We have all jumped onto that one risky product or service thinking it would be a great idea but never really implemented it for one reason or another." By Richard Silverstein, DPM

Dr. Dan Murphy - Lecture by Ryan Maloney, wavelengths

Low Level Laser Therapy Electron Volt Theory Synopsis of a Lecture by Ryan Maloney, explaning: Wavelengths

Dr. Dan Murphy DC, DABCO - Practical PAIN MANAGEM ENT, October 2007

"Conversely, anything that improves the flow of electrons through the respiratory chain will increase the production of ATP while reducing the generation of free radicals. This is the key to low-level laser therapy.

Broshyrer, prislista och media

Prislista handhållen laser 2019 - "Framtiden ser ljus ut!"

De senaste 30 årens forskning på fotonenergi och celler har idag lett till 16 stycken FDA-godkännanden av vår tillverkare Erchonia i USA. Området det forskas mest på just nu är hjärnhälsa. Den senaste kvadrupelblinda studien för nästa FDA-godkännande, påvisar en halvering av autismspektrum (NPF) inom åtta veckors behandling. Idag behandlas autism, depression, parkinson, smärta, neuropati, inflammationer, ische-miska sår och övervik

Flyer: FX-635

Världens enda FDA-godkända lågenergilaser för kronisk ländryggssmärta och plantarfasciit

Flyer - "Monday Morning Protocol"

MMP - Kursinnehåll

Lunula (Hand/Fot) i Media

DN - Särtryck, i samband med Almedalen uppmärkasmmades Lunula Laser


Hot vs. Cold Lasers - How They Work

A hot topic within the profession is the use of cold lasers.

FDA - 510(k) Summary for FX635

The Erchonia® FX-635 is low level laser system that uses three semi-conductor diodes (visible red-light) 630nm to 650nm. A variable hertz device. The FX-635 has been classified by the FDA/EC as a Class II/IIa device and a Class II/2 Laser. The FX-635 is indicated for use as an adjunct to provide relief of minor chronic low back pain of musculoskeletal origin and reducing chronic heel pain arising from plantar fasciitis

Don't Get Burned!

The facts about Class IV lasers

FDA Market Clears Erchonia’s FX 635 Laser for Chronic Low Back Pain

First and Only FDA Market Cleared Low-Level Laser Treatment Option. The success criteria were defined as a minimum of a 30% decrease in chronic low back pain and 35% of patients in the treated group would experience the minimum pain reduction compared to the placebo group. Overall, 72% of patients met the success criteria.

Class IV lasers and Cancer Article by NCI

What studies say about Class IV Lasers and specifically, their impact on cancer cells.

Cold Laser Therapy - Today's Chiropractic

What is Cold Laser Therapy or Low-Level Laser Therapy (LLLT)? How Cold Lasers Work Contraindications